Thursday, August 16, 2012 1:11:04 AM
Yes, we will see some more heavier investing here for quite some time...
8/14/12 MHTX just announced in a press release yesterday a significant milestones in pursuit of its early Cancer detection and treatment technology. Trading at $0.059 (up 11.3%), there is a grown number of investors also paying attention to their development.
No doubt, there has been a lot of funding in Cancer research, and solution & prevention can not only provide a HUGE benefit for society, it can also be a profitable venture.We are definitely keeping a close watch on MHTX a solid play to buy and hold long term - definitely the next few months will be interesting.
8/15/12 MHTX, - Making some key moves today. MHTX, - we will definitely be looking for any and all opportunities to load up even more. MHTX is gaining momentum last traded at $0.065 up 10% and getting very close to a new 52 week high - a definite sign of breakout to "Blue Sky" levels. We are watching Manhattan Scientifics, Inc. (MHTX) and this interesting story that is developing. MHTX caught our eye with Monday's press release. Business Wire(Mon, ug 13) Since its inception Manhattan Scientifics Inc. (MHTX) has been a technology developer that nurtures financially promising technologies with potential global commercial applications. Manhattan Scientifics has enjoyed a "Special informal relationship" and a lengthy successful history in tech-transfer from the Los lamos National Laboratory (LANL) and the Sandia National Laboratory (SNL). Manhattan Scientifics has enjoyed a "Special informal relationship" and a lengthy successful history in tech-transfer from the Los lamos National Laboratory (LANL) and the Sandia National Laboratory (SNL). MHTX recent press release marks a significant milestones in pursuit of its early Cancer detection and treatment technology. Trading at $0.064 (up 10.2%), we definitely see significant interest building and confirmed with increase daily trading volume over the past few days. This is a definite stock to hold for long term developments. bout Manhattan Scientifics Manhattan Scientifics, Inc., (OTCBB: MHTX), is a leading information age enterprise focused on the nanomedicine space. Located in New Mexico, New York and Montreal, Manhattan Scientifics' goal is to create profit for the company's shareholders through royalty-bearing licenses with Fortune 1000 companies by marketing products that rely on the company's patents, know-how and intellectual property. Manhattan Scientifics owns the exclusive, perpetual U.S. license to a family of patents which will enable the manufacture and marketing of super strong, ultra light-weight "nanostructured" metals that have been developed at the Los lamos National Laboratory (LANL) and in the former Soviet Union. More information about Manhattan Scientifics can be found at www.mhtx.com and at www.seniorscientific.com
8/14/12 MHTX just announced in a press release yesterday a significant milestones in pursuit of its early Cancer detection and treatment technology. Trading at $0.059 (up 11.3%), there is a grown number of investors also paying attention to their development.
No doubt, there has been a lot of funding in Cancer research, and solution & prevention can not only provide a HUGE benefit for society, it can also be a profitable venture.We are definitely keeping a close watch on MHTX a solid play to buy and hold long term - definitely the next few months will be interesting.
8/15/12 MHTX, - Making some key moves today. MHTX, - we will definitely be looking for any and all opportunities to load up even more. MHTX is gaining momentum last traded at $0.065 up 10% and getting very close to a new 52 week high - a definite sign of breakout to "Blue Sky" levels. We are watching Manhattan Scientifics, Inc. (MHTX) and this interesting story that is developing. MHTX caught our eye with Monday's press release. Business Wire(Mon, ug 13) Since its inception Manhattan Scientifics Inc. (MHTX) has been a technology developer that nurtures financially promising technologies with potential global commercial applications. Manhattan Scientifics has enjoyed a "Special informal relationship" and a lengthy successful history in tech-transfer from the Los lamos National Laboratory (LANL) and the Sandia National Laboratory (SNL). Manhattan Scientifics has enjoyed a "Special informal relationship" and a lengthy successful history in tech-transfer from the Los lamos National Laboratory (LANL) and the Sandia National Laboratory (SNL). MHTX recent press release marks a significant milestones in pursuit of its early Cancer detection and treatment technology. Trading at $0.064 (up 10.2%), we definitely see significant interest building and confirmed with increase daily trading volume over the past few days. This is a definite stock to hold for long term developments. bout Manhattan Scientifics Manhattan Scientifics, Inc., (OTCBB: MHTX), is a leading information age enterprise focused on the nanomedicine space. Located in New Mexico, New York and Montreal, Manhattan Scientifics' goal is to create profit for the company's shareholders through royalty-bearing licenses with Fortune 1000 companies by marketing products that rely on the company's patents, know-how and intellectual property. Manhattan Scientifics owns the exclusive, perpetual U.S. license to a family of patents which will enable the manufacture and marketing of super strong, ultra light-weight "nanostructured" metals that have been developed at the Los lamos National Laboratory (LANL) and in the former Soviet Union. More information about Manhattan Scientifics can be found at www.mhtx.com and at www.seniorscientific.com
